Monday, June 24, 2019

Krystal Biotech (KRYS) PT Nearly Doubled to $67 at Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros raised the price target on Krystal Biotech (NASDAQ: KRYS) to $67.00 (from $34.00)

at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.